Most Read Articles
3 days ago
A recent study has shown no improvement in the rate of blood pressure (BP) control despite an increase in the prevalence of antihypertensive medication use.
Roshini Claire Anthony, 11 Feb 2020

The consumption of processed meat or unprocessed red meat may be associated with a slightly elevated risk of incident cardiovascular disease (CVD)* and all-cause mortality, according to a US study.

29 Jan 2020
Several high-density lipoprotein (HDL) functionality parameters, which are linked to HDL roles on cholesterol metabolism, endothelial protection and antioxidant/anti-inflammatory defence, contribute to an increased risk of incident acute coronary syndromes and its manifestations in individuals at high risk of cardiovascular disease, a study reports.
Jairia Dela Cruz, 25 Nov 2019
Use of the PCSK9* inhibitor alirocumab in acute coronary syndrome (ACS) patients on a background of high-intensity statin treatment delivers reductions in total hospitalizations and death with corresponding gains in days alive and out of hospital (DAOH), according to the results of prespecified and posthoc analyses of the ODYSSEY OUTCOMES** trial presented at the American Heart Association (AHA) 2019 Scientific Sessions.

Cardiac imaging enhances detection of specific HF diagnoses compared with ECG

13 Feb 2020

Routine use of cardiac magnetic resonance (CMR) imaging is not superior to a selective use strategy in terms of refining the clinical categorization of heart failure (HF) aetiology in patients with nonischaemic HF, a study reports. However, CMR improves the detection of specific HF diagnoses compared with echocardiography (ECG), and specific HF aetiologies are associated with poor outcomes.

The study randomized 500 patients with nonischaemic HF (mean age, 59 years; 68.8 percent male) to undergo routine or selective CMR. Patients in the routine strategy underwent ECG and CMR whereas those assigned to selective use underwent ECG with or without CMR based on the clinical presentation. HF aetiology classification was done according to the imaging data, as well as by the treating physician at 3 months (primary outcome). Clinical events were collected for 12 months.

Rates of specific HF aetiologies at the 3-month follow-up were similar in the routine and selective CMR strategies (44 percent vs 50 percent, respectively; p=0.22). Likewise, the rates did not significantly differ on clinical assessment (34 percent vs 30 percent, respectively; p=0.34). However, a nonprotocol CMR was performed for 24 percent of patients in the selective group.

The frequency of clinical events was higher among patients with specific vs nonspecific HF aetiologies based on imaging classification (19 percent vs 12 percent, respectively; p=0.02) but not on clinical assessment (15 percent vs 14 percent; p=0.49).

The findings confirm that CMR should not be used routinely for diagnosing undifferentiated, nonischaemic HF, according to researchers. Additional studies are needed to evaluate the imaging modality’s role in specific nonischaemic populations, including patients with suspected inflammatory and infiltrative myocardial disease.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
A recent study has shown no improvement in the rate of blood pressure (BP) control despite an increase in the prevalence of antihypertensive medication use.
Roshini Claire Anthony, 11 Feb 2020

The consumption of processed meat or unprocessed red meat may be associated with a slightly elevated risk of incident cardiovascular disease (CVD)* and all-cause mortality, according to a US study.

29 Jan 2020
Several high-density lipoprotein (HDL) functionality parameters, which are linked to HDL roles on cholesterol metabolism, endothelial protection and antioxidant/anti-inflammatory defence, contribute to an increased risk of incident acute coronary syndromes and its manifestations in individuals at high risk of cardiovascular disease, a study reports.
Jairia Dela Cruz, 25 Nov 2019
Use of the PCSK9* inhibitor alirocumab in acute coronary syndrome (ACS) patients on a background of high-intensity statin treatment delivers reductions in total hospitalizations and death with corresponding gains in days alive and out of hospital (DAOH), according to the results of prespecified and posthoc analyses of the ODYSSEY OUTCOMES** trial presented at the American Heart Association (AHA) 2019 Scientific Sessions.